Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Special report
: Fierce 15 nominations are now open! We're looking for the best and brightest in biotech.
Roche
Biotech
Roche's $2.7B Carmot bet pays off with ph. 1 weight loss success
Roche’s incursion into obesity seems to be paying off based on the first readout since the drugmaker scooped up Carmot Therapeutics for $2.7 billion.
James Waldron
May 16, 2024 5:29am
FDA approves self-collection screening for HPV, cervical cancer
May 15, 2024 11:03am
Novo Nordisk's Hemlibra rival hits goals in phase 3
May 14, 2024 9:16am
Sanofi pays Fulcrum $80M for rights to phase 3 rare disease drug
May 13, 2024 7:09am
Roche's R&D rethink hits 20% of molecules as cancer drugs axed
Apr 24, 2024 4:27am
Pfizer closes R&D unit that spawned $7.1B anti-TL1A med
Apr 17, 2024 7:00am